Al-Modawat Specialized Medical Company (TADAWUL:9594)

Saudi Arabia · Delayed Price · Currency is SAR

4.790

+0.020 (0.42%)

Sep 3, 2026, 2:59 PM AST

TADAWUL:9594 Financials Overview

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	138.96	121.82	75.49	74.31	58.57	40.84
Revenue Growth	48.75%	61.38%	1.59%	26.88%	43.41%	-
Gross Profit	53.6	52.06	30.4	40.37	27.85	14.67
Operating Income	21.43	23.99	8.04	21.88	12.14	-0.48
Net Income	14.68	18.98	6.07	18.59	10.31	-2.21
Earnings Per Share	0.21	0.27	0.09	0.33	0.18	-
EPS Growth	11.78%	203.88%	-73.13%	80.28%	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Medical Services	111.43	70.15	70.91	55.52
Pharmaceutical Products	5.69	4.56	3.4	3.05
Other	4.7	0.78	-	-
Total	121.82	75.49	74.31	58.57

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	35.49	12.12	15.77	0.27	1.39	6.77
Total Debt	52.12	32.48	16.34	9.19	8.6	7.86
Net Cash (Debt)	-16.63	-20.37	-0.57	-8.91	-7.21	-1.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.23	-0.29	-0.01	-0.16	-0.13	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	21.65	4.28	10.07	13.6	5.09	2.27
Capital Expenditures	-0.32	-2.38	-18.59	-3.92	-2.77	-4.53
Free Cash Flow	21.33	1.9	-8.52	9.68	2.32	-2.26
Free Cash Flow Growth	-	-	-	317.48%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.57%	42.74%	40.27%	54.33%	47.56%	35.92%
Operating Margin	15.42%	19.69%	10.65%	29.44%	20.73%	-1.17%
Pretax Margin	11.60%	16.65%	9.00%	26.17%	18.12%	-1.70%
Profit Margin	10.56%	15.58%	8.04%	25.02%	17.61%	-5.40%
FCF Margin	15.35%	1.56%	-11.29%	13.03%	3.96%	-5.53%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.120	-	-	0.233
Dividend Per Share Growth	500.00%	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	23.25	17.74	66.48	-	-	-
P/FCF Ratio	16.00	177.04	-	-	-	-
PS Ratio	2.46	2.76	5.35	-	-	-